Postpartum Weight Loss and Exercise (PRIDE)

Early Postpartum Treatment of Gestational Diabetes With Weight Loss and Exercise

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01296516

Acronym

PRIDE

Enrollment

Registered

2011-02-15

Start date

2011-02-28

Completion date

2017-12-31

Last updated

2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Glucose Intolerance

Keywords

Women, Postpartum, GDM

Brief summary

The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.

Detailed description

The objective is in comparison to a group of women not enrolled in the lifestyle intervention, 8 months of intensive lifestyle intervention aimed at promoting 7% weight loss through increased physical activity and dietary modification in women with a history of GDM will: 1. decrease body weight and 2. reduce the rate of metabolic abnormalities, 12 months after delivery

Interventions

BEHAVIORALNon-intervention group

A pedometer and written material on a healthy lifestyle.

BEHAVIORALFace to face

Motivational meetings held once per week; Behavioral sessions weill be led by a trained interventionist.

BEHAVIORALTelehelath Group

Participants will speak to Trestletree personnel once a week via phone.

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

PREVENTION

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Women are required to be enrolled (provided written consent for participation) in the COPSS-GDM study and therefore have met the following inclusion criteria: * Postpartum Women ≥18 years to 45 years (inclusive) of age who experienced GDM during index pregnancy * English-speaking

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Incidence of glucose intolerance	8 Months	To examine the incidence of glucose abnormalities (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and health outcomes (changes in body fat, waist circumference and blood lipids)in women with a history of gestational diabetes, 12 months postpartum.

Secondary

Measure	Time frame	Description
Weight loss	8 months	Weight loss through increased physical activity and dietary modification will achieve similar results when delivered via face-to-face contact (DPP) or via telehealth

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026